I have seen far more muscle lost to skipped sessions and lazy eating than to any metabolic compound
It works by stimulating GLP-1 receptors in the brain, which causes the body to feel full after eating smaller portions of food
More emphasis needs to be put on supporting those who actually are running trials trying to figure out this information or forcing large phase 3 trials (who are collecting this data) to actually report on the outcomes, so we can provide evidence based DIET & EXERCISE recommendations
Retatrutide: Designed to Last One of the newest GLP-1 medications in development is retatrutide , a triple agonist (GLP-1, GIP, and glucagon receptors) designed with an approximate 6-day half-life , thanks to advanced pharmaceutical engineering
Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist: a pilot study
The gap between perceived intake and actual intake on significant caloric restriction is usually larger than most people expect
